Fed. Circ. Upholds PTAB Ax Of Avastin Patent
The Federal Circuit on Wednesday upheld a Patent Trial and Appeal Board ruling that invalidated a patent covering drugmaker Genentech Inc.'s blockbuster cancer drug Avastin....To view the full article, register now.
Already a subscriber? Click here to view full article